Case Report
Treating Primary Arthroprosthesis Infection Caused by Mycobacterium abscessus subsp. abscessus
Table 2
Mycobacterium abscessus subsp.
abscessus:
in vitro antibiotic susceptibility and genome sequencing results. Breakpoints according to CLSI [
19].
| Antibiotics | 07.02.2018 | 08.07.2018 | 10.01.2018 | 10.02.2018 |
| | 4-day reading (mg/L) | 4-day reading (mg/L) | 14-day reading (mg/L) | 14-day reading (mg/L) | | | | | | | 23s-wild type-macrolide constitutive resistance not detected | 16s-wild type-susceptible to amikacin erm(41)-wild type-macrolide-inducible resistance detected | Amikacin | 3 (S) | | | 16 (S) | | Tigecyclin | 0.5 (S) | | | 0.75 (S) | | Clarithromycin | 0.5 (S) | 1.5 (S) | 4 (R) | 4 (R) | | Imipenem | 4 (S) | | | 32 (R) | | Linezolid | 8 (R) | | | >256 (R) | | Azitromycin | 128 (R) | | | | | Moxifloxacin | >32 (R) | | | | | Gentamycin | 12 (R) | | | | |
|
|
E-test, Middlebrook 7H-11 agar; broth microdilution testing, Middlebrook 7H-9 broth. |